{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:27:24Z","timestamp":1785824844840,"version":"3.56.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s40261-022-01143-9","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T12:04:03Z","timestamp":1650888243000},"page":"47-53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Management of Alcohol-Related Liver Disease and Its Complications"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0012-484X","authenticated-orcid":false,"given":"Joaqu\u00edn","family":"Cabezas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"issue":"1 Suppl","key":"1143_CR1","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.jhep.2015.03.006","volume":"62","author":"P Mathurin","year":"2015","unstructured":"Mathurin P, Bataller R. Trends in the management and burden of alcoholic liver disease. J Hepatol. 2015;62(1 Suppl):S38-46.","journal-title":"J Hepatol"},{"issue":"5","key":"1143_CR2","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141(5):1572\u201385.","journal-title":"Gastroenterology"},{"issue":"3","key":"1143_CR3","doi-asserted-by":"publisher","first-page":"e013620","DOI":"10.1136\/bmjopen-2016-013620","volume":"7","author":"N Ndugga","year":"2017","unstructured":"Ndugga N, Lightbourne TG, Javaherian K, et al. Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USA. BMJ Open. 2017;7(3):e013620.","journal-title":"BMJ Open"},{"issue":"1","key":"1143_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.30866","volume":"71","author":"DW Crabb","year":"2020","unstructured":"Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology. 2020;71(1):306\u201333.","journal-title":"Hepatology"},{"issue":"10","key":"1143_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.gastrohep.2019.09.006","volume":"42","author":"R Bataller","year":"2019","unstructured":"Bataller R, Cabezas J, Aller R, et al. Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. Gastroenterol Hepatol. 2019;42(10):657\u201376.","journal-title":"Gastroenterol Hepatol"},{"issue":"2","key":"1143_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ajg.2017.469","volume":"113","author":"AK Singal","year":"2018","unstructured":"Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018;113(2):175\u201394.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1143_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.dld.2019.12.008","volume":"52","author":"G Addolorato","year":"2020","unstructured":"Addolorato G, Abenavoli L, Dallio M, Federico A, Germani G, Gitto S, Leandro G, Loguercio C, Marra F, Stasi E. Alcohol associated liver disease 2020: a clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis. 2020;52(4):374\u201391.","journal-title":"Dig Liver Dis"},{"key":"1143_CR8","doi-asserted-by":"publisher","first-page":"140329","DOI":"10.5888\/pcd11.140329","volume":"11","author":"MB Esser","year":"2014","unstructured":"Esser MB, Hedden SL, Kanny D, Brewer RD, Gfroerer JC, Naimi TS. Prevalence of alcohol dependence among US adult drinkers, 2009\u20132011. Prev Chronic Dis. 2014;11:140329.","journal-title":"Prev Chronic Dis"},{"issue":"3","key":"1143_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","volume":"5","author":"GBD 2017 Cirrhosis Collaborators","year":"2020","unstructured":"GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245\u201366.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"3","key":"1143_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2468-1253(16)30081-4","volume":"1","author":"P Gin\u00e8s","year":"2016","unstructured":"Gin\u00e8s P, Graupera I, Lammert F, Angeli P, Caballeria L, Krag A, Guha IN, Murad SD, Castera L. Screening for liver fibrosis in the general population: a call for action. Lancet Gastroenterol Hepatol. 2016;1(3):256\u201360.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"8","key":"1143_CR11","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1053\/j.gastro.2016.03.005","volume":"150","author":"Z Younossi","year":"2016","unstructured":"Younossi Z, Henry L. Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality. Gastroenterology. 2016;150(8):1778\u201385.","journal-title":"Gastroenterology"},{"issue":"4","key":"1143_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jhep.2010.07.016","volume":"54","author":"TD Sandahl","year":"2011","unstructured":"Sandahl TD, Jepsen P, Thomsen KL, Vilstrup H. Incidence and mortality of alcoholic hepatitis in Denmark 1999\u20132008: a nationwide population based cohort study. J Hepatol. 2011;54(4):760\u20134.","journal-title":"J Hepatol"},{"issue":"3","key":"1143_CR13","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/hep.29887","volume":"68","author":"JL Mellinger","year":"2018","unstructured":"Mellinger JL, Shedden K, Winder GS, et al. The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology. 2018;68(3):872\u201382.","journal-title":"Hepatology"},{"issue":"24","key":"1143_CR14","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2020.4501","volume":"323","author":"G Hirode","year":"2020","unstructured":"Hirode G, Wong RJ. Trends in the prevalence of metabolic syndrome in the United States, 2011\u20132016. JAMA. 2020;323(24):2526\u20138.","journal-title":"JAMA"},{"issue":"12","key":"1143_CR15","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1111\/liv.13481","volume":"37","author":"D Roulot","year":"2017","unstructured":"Roulot D, Roudot-Thoraval F, NKontchou G, et al. Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan. Liver Int. 2017;37(12):1897\u2013906.","journal-title":"Liver Int"},{"issue":"3","key":"1143_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1001\/jamainternmed.2018.6536","volume":"179","author":"BP Lee","year":"2019","unstructured":"Lee BP, Vittinghoff E, Dodge JL, Cullaro G, Terrault NA. National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States. JAMA Intern Med. 2019;179(3):340\u20138.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"1143_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cld.2016.02.008","volume":"20","author":"MF Dugum","year":"2016","unstructured":"Dugum MF, McCullough AJ. Acute alcoholic hepatitis, the clinical aspects. Clin Liver Dis. 2016;20(3):499\u2013508.","journal-title":"Clin Liver Dis"},{"key":"1143_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.4321\/S1135-57272014000400007","volume":"88","author":"I Gal\u00e1n","year":"2014","unstructured":"Gal\u00e1n I, Gonz\u00e1lez M, Valencia-Mart\u00edn J. Patrones de consumo de alcohol en Espa\u00f1a: un pa\u00eds en transici\u00f3n. Rev Esp Salud Publica. 2014;88:529\u201340.","journal-title":"Rev Esp Salud Publica"},{"key":"1143_CR19","unstructured":"CDC\/National Institute on Alcohol Abuse and Alcolism. Drinking levels defined. https:\/\/www.niaaa.nih.gov\/alcohol-health\/overview-alcohol-consumption\/moderate-binge-drinking. Accessed 11 Jul 2021."},{"key":"1143_CR20","unstructured":"World Health Organization. Global Status Report on Alcohol and Health 2014. Editors: Poznyak, Vladimir and Rekve, Dag. https:\/\/www.who.int\/substance_abuse\/publications\/alcohol_2014\/en\/. Accessed 20 July 2021."},{"key":"1143_CR21","unstructured":"UK Chief Medical Officers\u2019 Low Risk Drinking Guidelines 2016. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/545937\/UK_CMOs__report.pdf. Accessed 15 Jul 2021."},{"issue":"Suppl 1","key":"1143_CR22","doi-asserted-by":"publisher","first-page":"E253","DOI":"10.1111\/j.1530-0277.2012.01898.x","volume":"37","author":"JA Johnson","year":"2013","unstructured":"Johnson JA, Lee A, Vinson D, Seale JP. Use of AUDIT-based measures to identify unhealthy alcohol use and alcohol dependence in primary care: a validation study. Alcohol Clin Exp Res. 2013;37(Suppl 1):E253\u20139.","journal-title":"Alcohol Clin Exp Res"},{"issue":"13","key":"1143_CR23","first-page":"515","volume":"91","author":"L Caballero Mart\u00ednez","year":"1988","unstructured":"Caballero Mart\u00ednez L, Caballero Mart\u00ednez F, Santodomingo CJ. Instrumentos de detecci\u00f3n de alcoholismo: precisiones sobre el cuestionario CAGE [Instruments for detecting alcoholism: remarks on the CAGE questionnaire]. Med Clin (Barc). 1988;91(13):515 (Spanish).","journal-title":"Med Clin (Barc)"},{"key":"1143_CR24","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018;69(1):154-181."},{"issue":"9","key":"1143_CR25","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1097\/MEG.0000000000000392","volume":"27","author":"M Fernandez","year":"2015","unstructured":"Fernandez M, Tr\u00e9po E, Degr\u00e9 D, Gustot T, Verset L, Demetter P, Devi\u00e8re J, Adler M, Moreno C. Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease. Eur J Gastroenterol Hepatol. 2015;27(9):1074\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"1143_CR26","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1053\/j.gastro.2018.01.005","volume":"154","author":"M Thiele","year":"2018","unstructured":"Thiele M, Madsen BS, Hansen JF, Detlefsen S, Antonsen S, Krag A. Accuracy of the enhanced liver fibrosis test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease. Gastroenterology. 2018;154(5):1369\u201379.","journal-title":"Gastroenterology"},{"issue":"23","key":"1143_CR27","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.3748\/wjg.v27.i23.3223","volume":"27","author":"D Fuster","year":"2021","unstructured":"Fuster D, Garc\u00eda-Calvo X, Zuluaga P, Bolao F, Muga R. Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use. World J Gastroenterol. 2021;27(23):3223\u201337.","journal-title":"World J Gastroenterol"},{"key":"1143_CR28","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3748\/wjg.v16.i8.966","volume":"16","author":"S Mueller","year":"2010","unstructured":"Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, Eisele S, Stickel F, Longerich T, Schirmacher P, Seitz HK. Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol. 2010;16:966\u201372.","journal-title":"World J Gastroenterol"},{"key":"1143_CR29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S2468-1253(18)30124-9","volume":"3","author":"E Nguyen-Khac","year":"2018","unstructured":"Nguyen-Khac E, Thiele M, Voican C, Nahon P, Moreno C, Boursier J, Mueller S, de Ledinghen V, St\u00e4rkel P, Gyune Kim S, Fernandez M, Madsen B, Naveau S, Krag A, Perlemuter G, Ziol M, Chatelain D, Diouf M. Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis. Lancet Gastroenterol Hepatol. 2018;3:614\u201325.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"1143_CR30","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jhep.2008.08.011","volume":"49","author":"P Nahon","year":"2008","unstructured":"Nahon P, Kettaneh A, Tengher-Barna I, Ziol M, de L\u00e9dinghen V, Douvin C, Marcellin P, Ganne-Carri\u00e9 N, Trinchet JC, Beaugrand M. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol. 2008;49:1062\u20138.","journal-title":"J Hepatol"},{"key":"1143_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/MCG.0b013e3181cb4216","volume":"44","author":"F Janssens","year":"2010","unstructured":"Janssens F, de Suray N, Piessevaux H, Horsmans Y, de Timary P, St\u00e4rkel P. Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: a real-life study. J Clin Gastroenterol. 2010;44:575\u201382.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"1143_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/cld.571","volume":"8","author":"J Cabezas","year":"2016","unstructured":"Cabezas J, Lucey MR, Bataller R. Biomarkers for monitoring alcohol use. Clin Liver Dis (Hoboken). 2016;8(3):59\u201363.","journal-title":"Clin Liver Dis (Hoboken)."},{"issue":"10","key":"1143_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.gastrohep.2019.09.006","volume":"42","author":"R Bataller","year":"2019","unstructured":"Bataller R, Cabezas J, Aller R, Ventura-Cots M, Abad J, Albillos A, Altamirano J, Arias-Loste MT, Ba\u00f1ares R, Caballer\u00eda J, Caballer\u00eda L, Carri\u00f3n JA, Diago M, Fern\u00e1ndez Rodr\u00edguez C, Gallego R, Garc\u00eda-Cortes M, Garc\u00eda-Monz\u00f3n C, Genesc\u00e0 J, Gin\u00e9s P, Hernandez-Guerra M, Jorquera F, Lligo\u00f1a A, Molina E, Pareja MJ, Planas R, Tom\u00e9 S, Salmer\u00f3n J, Romero-G\u00f3mez M. Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. Gastroenterol Hepatol. 2019;42(10):657\u201376.","journal-title":"Gastroenterol Hepatol"},{"issue":"5","key":"1143_CR34","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1360-0443.2009.02521.x","volume":"104","author":"C Verril","year":"2009","unstructured":"Verril C, Markham H, Templeton A, Carr NJ, Sheron N. Alcohol-related cirrhosis\u2014early abstinence is a key factor in prognosis, even in the most severe cases. Addiction. 2009;104(5):768\u201374.","journal-title":"Addiction"},{"issue":"5","key":"1143_CR35","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/hep.29240","volume":"66","author":"A Louvet","year":"2017","unstructured":"Louvet A, Labreuche J, Artru F, et al. Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study. Hepatology. 2017;66(5):1464\u201373.","journal-title":"Hepatology"},{"key":"1143_CR36","doi-asserted-by":"publisher","first-page":"c1240","DOI":"10.1136\/bmj.c1240","volume":"340","author":"CL Hart","year":"2010","unstructured":"Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey SG. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ. 2010;340:c1240.","journal-title":"BMJ"},{"issue":"6","key":"1143_CR37","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/hep.23527","volume":"51","author":"MS Ascha","year":"2010","unstructured":"Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51(6):1972\u20138.","journal-title":"Hepatology"},{"issue":"4","key":"1143_CR38","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","volume":"150","author":"DW Crabb","year":"2016","unstructured":"Crabb DW, Bataller R, Chalasani NP, et al. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia. Gastroenterology. 2016;150(4):785\u201390.","journal-title":"Gastroenterology"},{"issue":"4","key":"1143_CR39","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/hep.28530","volume":"64","author":"P Mandrekar","year":"2016","unstructured":"Mandrekar P, Bataller R, Tsukamoto H, Gao B. Alcoholic hepatitis: translational approaches to develop targeted therapies. Hepatology. 2016;64(4):1343\u201355.","journal-title":"Hepatology"},{"issue":"5","key":"1143_CR40","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","volume":"146","author":"J Altamirano","year":"2014","unstructured":"Altamirano J, Miquel R, Katoonizadeh A, et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology. 2014;146(5):1231-9.e1-6.","journal-title":"Gastroenterology"},{"issue":"2","key":"1143_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hep.29080","volume":"66","author":"J Bissonnette","year":"2017","unstructured":"Bissonnette J, Altamirano J, Devue C, et al. A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis. Hepatology. 2017;66(2):555\u201363.","journal-title":"Hepatology"},{"issue":"2","key":"1143_CR42","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","volume":"137","author":"A Louvet","year":"2009","unstructured":"Louvet A, Wartel F, Castel H, et al. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology. 2009;137(2):541\u20138.","journal-title":"Gastroenterology"},{"issue":"4","key":"1143_CR43","first-page":"463","volume":"15","author":"V Prado","year":"2016","unstructured":"Prado V, Caballer\u00eda J, Vargas V, Bataller R, Altamirano J. Alcoholic hepatitis: How far are we and where are we going? Ann Hepatol. 2016;15(4):463\u201373.","journal-title":"Ann Hepatol"},{"issue":"12","key":"1143_CR44","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/lt.25328","volume":"24","author":"R Sujan","year":"2018","unstructured":"Sujan R, Cruz-Lemini M, Altamirano J, et al. A validated score predicts acute kidney injury and survival in patients with alcoholic hepatitis. Liver Transpl. 2018;24(12):1655\u201364.","journal-title":"Liver Transpl"},{"key":"1143_CR45","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018;69(1):154-81."},{"issue":"19","key":"1143_CR46","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","volume":"365","author":"E Nguyen-Khac","year":"2011","unstructured":"Nguyen-Khac E, Thevenot T, Piquet MA, et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med. 2011;365(19):1781\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"1143_CR47","doi-asserted-by":"publisher","first-page":"e0190823","DOI":"10.1371\/journal.pone.0190823","volume":"13","author":"A Marot","year":"2018","unstructured":"Marot A, Dubois M, Tr\u00e9po E, Moreno C, Deltenre P. Liver transplantation for alcoholic hepatitis: a systematic review with meta-analysis. PLoS ONE. 2018;13(1):e0190823.","journal-title":"PLoS ONE"},{"issue":"6","key":"1143_CR48","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/hep.29338","volume":"66","author":"J Altamirano","year":"2017","unstructured":"Altamirano J, L\u00f3pez-Pelayo H, Michelena J, et al. Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival. Hepatology. 2017;66(6):1842\u201353.","journal-title":"Hepatology"},{"issue":"1","key":"1143_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.transproceed.2018.02.212","volume":"51","author":"P Magistri","year":"2019","unstructured":"Magistri P, Marzi L, Guerzoni S, et al. Impact of a multidisciplinary team on alcohol recidivism and survival after liver transplant for alcoholic disease. Transplant Proc. 2019;51(1):187\u20139.","journal-title":"Transplant Proc"},{"issue":"2","key":"1143_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2018.10.026","volume":"70","author":"AK Singal","year":"2019","unstructured":"Singal AK, Shah VH. Current trials and novel therapeutic targets for alcoholic hepatitis. J Hepatol. 2019;70(2):305\u201313.","journal-title":"J Hepatol"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01143-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-022-01143-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01143-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T10:22:13Z","timestamp":1655461333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-022-01143-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":50,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1143"],"URL":"https:\/\/doi.org\/10.1007\/s40261-022-01143-9","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"16 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article has been published as a part of a journal supplement wholly funded by Eisai.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}},{"value":"No funding or sponsorship was received for this study. Support for editorial assistance was funded by Eisai.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there were no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability (software application or custom code)"}},{"value":"All authors have contributed to the conception and design, analysis and interpretation of data, drafting the article and revising it critically for important intellectual content, and to the final approval of the version to be published.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contribution"}}]}}